79 related articles for article (PubMed ID: 14668030)
1. Platelet counts and interleukin-6 (IL-6) promoter polymorphism in patients with Gaucher disease.
Elstein D; Altarescu G; Zimran A
Hematology; 2003 Dec; 8(6):367-8. PubMed ID: 14668030
[TBL] [Abstract][Full Text] [Related]
2. The interleukin-6 promoter polymorphism in Gaucher disease: a new modifier gene?
Altarescu G; Phillips M; Foldes AJ; Elstein D; Zimran A; Mates M
QJM; 2003 Aug; 96(8):575-8. PubMed ID: 12897342
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.
Magal I; Lebel E; Altarescu G; Itzchaki M; Rudensky B; Foldes AJ; Zimran A; Elstein D
Br J Haematol; 2006 Apr; 133(1):93-7. PubMed ID: 16512834
[TBL] [Abstract][Full Text] [Related]
4. Proteinase-activated receptor (PAR1) polymorphic variant correlates with thrombocytopenia in Gaucher disease.
Altarescu G; Seror-Bukris O; Zimran A; Elstein D
Blood Cells Mol Dis; 2010; 44(2):79-81. PubMed ID: 19969492
[TBL] [Abstract][Full Text] [Related]
5. The 1604A (R496H) mutation in Gaucher disease: genotype/phenotype correlation.
Brautbar A; Elstein D; Abrahamov A; Zeigler M; Chicco G; Beutler E; Scott CR; Zimran A
Blood Cells Mol Dis; 2003; 31(2):187-9; discussion 190-1. PubMed ID: 12972024
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha levels and TNF-alpha gene polymorphism in type I Gaucher disease.
Altarescu G; Zimran A; Michelakakis H; Elstein D
Cytokine; 2005 Jul; 31(2):149-52. PubMed ID: 15919211
[TBL] [Abstract][Full Text] [Related]
7. α-Synuclein rs356219 polymorphisms in patients with Gaucher disease and Parkinson disease.
Altarescu G; Ioscovich D; Alcalay RN; Zimran A; Elstein D
Neurosci Lett; 2014 Sep; 580():104-7. PubMed ID: 25111979
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-18 gene promoter--607 A/C polymorphism and the risk of immune thrombocytopenia.
Zhao H; Zhang Y; Xiao G; Wu N; Xu J; Fang Z
Autoimmunity; 2014 Nov; 47(7):478-81. PubMed ID: 24897237
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
[TBL] [Abstract][Full Text] [Related]
10. The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults.
Kilpinen S; Hulkkonen J; Wang XY; Hurme M
Eur Cytokine Netw; 2001 Mar; 12(1):62-8. PubMed ID: 11282548
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic heterogeneity in patients with Gaucher disease and the N370S/V394L genotype.
Elstein D; Scott CR; Zeigler M; Abrahamov A; Zimran A
Genet Test; 2005; 9(1):26-9. PubMed ID: 15857183
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world.
Sobreira E; Pires RF; Cizmarik M; Grabowski GA
Mol Genet Metab; 2007 Jan; 90(1):81-6. PubMed ID: 16996765
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in glucosylceramide (glucocerebroside) synthase and the Gaucher disease phenotype.
Beutler E; West C
Isr Med Assoc J; 2002 Nov; 4(11):986-8. PubMed ID: 12489486
[TBL] [Abstract][Full Text] [Related]
14. Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications.
Sibille A; Eng CM; Kim SJ; Pastores G; Grabowski GA
Am J Hum Genet; 1993 Jun; 52(6):1094-101. PubMed ID: 8503443
[TBL] [Abstract][Full Text] [Related]
15. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
[TBL] [Abstract][Full Text] [Related]
17. Asymptomatic Gaucher disease implications for large-scale screening.
Azuri J; Elstein D; Lahad A; Abrahamov A; Hadas-Halpern I; Zimran A
Genet Test; 1998; 2(4):297-9. PubMed ID: 10464607
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 gene -174 G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India.
Chakraborty B; Chowdhury D; Vishnoi G; Goswami B; Kishore J; Agarwal S
J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):683-9. PubMed ID: 22410655
[TBL] [Abstract][Full Text] [Related]
19. Gaucher disease in Spanish patients: analysis of eight mutations.
Cormand B; Vilageliu L; Burguera JM; Balcells S; Gonzàlez-Duarte R; Grinberg D; Chabás A
Hum Mutat; 1995; 5(4):303-9. PubMed ID: 7627184
[TBL] [Abstract][Full Text] [Related]
20. Thromboelastography as a Surrogate Marker of Perisurgical Hemostasis in Gaucher Disease.
Ioscovich A; Fadeev D; Kenet G; Naamad M; Schtrechman G; Zimran A; Elstein D
Clin Appl Thromb Hemost; 2016 Oct; 22(7):693-7. PubMed ID: 25818635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
